Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Rhythm Effect on Dance Learning in Typical Development Children and Children With Motor Disorders.

NCT06137625 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2024-07-02
Last updated
2025-12-31

Condition(s) studied

Cerebral Palsy (CP)

Investigational drug(s) / intervention(s)

With regular rhythmWithout regular rhythm

With regular rhythm: All children learn one dance choreographie with regular rhythm music.The pre-recorded choreography is displayed on a large screen in front of the child. The child practices the choreography by imitating the models in order to learn the sequence movements.

Without regular rhythm: All children learn one dance choreographie without regular rhythm music.The pre-recorded choreography is displayed on a large screen in front of the child. The child practices the choreography by imitating the models in order to learn the sequence movements.

Study summary

Cerebral Palsy (CP) or Developmental Coordination Disorder (DCD) leads to motor troubles impacting the everyday life, social participation and academic difficulty . According to some authors, CP and DCD pertain to a same continuum of motor disorders (MD) (Pearsall-Jones et al., 2010).Those children show an alteration in Perceptivo-Motor Procedural Learning (PMPL), corresponding to the acquisition of everyday life skill (for CP: Gagliardi et al., 2011; Gofer-Levi et al., 2013; for DCD: Gheysen et al., 2011; Blais et al., 2018). Also, recommended rehabilitation for this population are based on procedural learnings (for CP: Novak et al., 2013; for DCD: Blank et al., 2019; Inserm, 2019). It's true for dancing which present high evidence to enhance motor, cognitive, psychoaffective and social functions of this children (Cherriere, Martel, et al., 2020; Cherriere, Robert, et al., 2020). Dance is a physical activity that involve procedural learning to memorise movement sequences (choreography). Rhythm can be define as a stimuli repetition at a regular interval (Grahn \& Brett, 2007; Patel, 2003). Recently studies tend to shown that rhythm is essential to enhance motor control and procedural learning (Ghai et al., 2022; Lagarrigue et al., 2021). To validate this hypothesis, the investigators will evaluate typical development children and children with CP MD learning of a dance choreography with and without rhythm.

Eligibility

Sex
ALL
Min age
8 Years
Max age
16 Years
Healthy volunteers
Accepted
Inclusion Criteria: For all the participants: * Aged from 8 to 16 include. * Free, informed, written, and signed consent of the holders of parental authority * Free and informed consent of the minor * Affiliation with or benefiting from a social security scheme. * Ability to understand the instructions (investigator's assessment) For the participant with Motor disorders (MD): 1. For children with CP: * CP diagnosis * Gross Motor Function Classification System level between I to IV. * Manual Ability Classification System level between I to IV. 2. For children with DCD: * A diagnosis of DCD For the participant with typical development: * No CP diagnosis * No neurological trouble nor functional disfunction including developmental coordination disorder. Exclusion Criteria: * -Autism spectrum disorder diagnosed according to the DSM-5 (APA, 2015) * Hearing deficiency diagnosed according to the DSM-5 (APA, 2015) or uncorrected hearing deficiency that doesn't allows the participant to hear a music with a sound level between 45 and 70 decibels. * Visual deficiency diagnosed according to the DSM-5 (APA, 2015) * Intellectual developmental disorder diagnosed according to the DSM-5 (APA, 2015) * Behavioural disorders diagnosed according to the DSM-5 (APA, 2015) * Diagnosed epilepsia * Pregnancy (check in young pubescent and sexually active women) or breastfeeding. * Children already include in ongoing interventional study. * Children with both parent who benefit of legal protection (guardianship, curatorship, safeguard of justice).

Primary outcome measure(s)

  • Retention score of the choreography — Day 0
    Number of movements in the choreography performed correctly and in order after practice is analysed by video using a standardised observation grid scored independently and blind to the condition by two trained judges.

Trial sites (1)

FacilityCityRegionStatus
Toulouse Hospital Toulouse France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06137625 on ClinicalTrials.gov ↗ ← All trials in France